Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30
- PMID: 6299171
Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30
Abstract
Antibodies cross-reactive with type C viral p30 were concentrated from 105 samples of human plasma by affinity chromatography using Sepharose beads to which disrupted Simian sarcoma associated virus (SSAV) had been coupled. Eluates obtained from the affinity beads were tested for anti-p30 activity by performing radio-immunoprecipitations with 125I-labeled SSAV p30 and Rauscher murine leukemia viral (R-MuLV) p30. Forty six percent of the eluates were found positive when tested against SSAV p30. From 44 positive eluates for anti SSAV p30 activity, 20 (45%) were also found to be positive for anti-R-MuLV p30 activity. No significant difference was found in anti-p30 activity in eluates from normal controls and from patients with various kinds of malignancy.
Similar articles
-
Detection of antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluids.Cancer Res. 1980 Jan;40(1):166-73. Cancer Res. 1980. PMID: 6243087
-
Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with Simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient.Cancer Res. 1982 Feb;42(2):681-6. Cancer Res. 1982. PMID: 6173117
-
Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (Mr 30,000).Cancer Res. 1983 Jan;43(1):392-9. Cancer Res. 1983. PMID: 6291760
-
Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas.Am J Pathol. 1983 Sep;112(3):347-56. Am J Pathol. 1983. PMID: 6311020 Free PMC article.
-
Serum antibody reacting with placental syncytiotrophoblast in sera of patients with autoimmune diseases--a possible relation to type C RNA retrovirus.Clin Exp Immunol. 1985 Jun;60(3):645-53. Clin Exp Immunol. 1985. PMID: 2990781 Free PMC article.